Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intra-Cellular Ther (ITCI)

Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Intra-Cellular Ther 430 EAST 29TH STREET NEW YORK NY 10016 USA

www.intracellulartherapies.com P: 646-440-9333 F: 646-440-9334

Description:

Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 7,154,817
Enterprise Value, $K 7,005,297
Shares Outstanding, K 105,575
Annual Sales, $ 464,370 K
Annual Net Income, $ -139,670 K
Last Quarter Sales, $ 144,870 K
Last Quarter Net Income, $ -15,250 K
EBIT, $ -131,940 K
EBITDA, $ -139,810 K
60-Month Beta 0.98
% of Insider Shareholders 3.40%
% of Institutional Shareholders 92.33%
Float, K 101,985
% Float 96.60%
Short Volume Ratio 0.37

Growth:

1-Year Return 7.69%
3-Year Return 65.95%
5-Year Return 430.59%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 48.59%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 05/07/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -1.16
EPS Growth vs. Prev Qtr 46.67%
EPS Growth vs. Prev Year 65.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ITCI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -18.49%
Return-on-Assets % -15.26%
Profit Margin % -30.08%
Debt/Equity 0.00
Price/Sales 15.41
Price/Cash Flow N/A
Price/Book 10.94
Book Value/Share 6.19
Interest Coverage -0.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar